Skip to main content
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

Antimicrobial resistance national action plan – call for evidence

The government is developing the next 5-year national action plan on antimicrobial resistance (AMR). The plan will run from 2024 until 2029. Input is encouraged from technical experts – including on human health, animal and plant health, food and AMR in the environment. The action plans are part of a programme to tackle AMR and achieve the UK’s vision for AMR to be contained and…
Natalie Creaney
November 25, 2022
Membership NewsMembership News Archive

BIVDA contributes to World Antimicrobial Awareness Week 2022

Doris-Ann has highlighted the dangers of AMR during World Antimicrobial Awareness Week 2022 – including authoring an article and reaching millions through radio interviews. As part of a Mediaplanet campaign, Doris-Ann composed an article titled, “How can diagnostic tests help with antimicrobial resistance in the UK?”, which was featured in The Guardian yesterday; bringing the link between AMR and IVDs…
Natalie Creaney
November 25, 2022
Infectious Diseases Working PartyInfectious Diseases Working Party ArchiveMember RequestsMember Requests Archive

Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2021 report

Scottish One Health Antimicrobial Use and Antimicrobial Resistance (SONAAR) in 2021 report has produced a series of findings which may be of interest to members. Notable statistics include: Total antibiotic use in humans has decreased by 16.9% in Scotland since 2017 and have decreased by 8.6% in acute hospitals since 2017. Members can read the full report and the report…
Natalie Creaney
November 18, 2022
Membership NewsMembership News Archive

Innovate UK launches programme to help grow SME’s AMR opportunities

Innovate UK have launched a programme which aims to help grow SME’s AMR opportunities, with this phase focused on Germany and Switzerland. Delivered by Innovate UK EDGE, the programme consists of a preparation phase, a five-day innovation visit focussed on Antimicrobial Resistance (AMR), a post-visit exploitation workshop and support for approximately 12 months from an Innovate UK EDGE Innovation and…
Natalie Creaney
November 11, 2022
Membership NewsMembership News Archive

BIVDA attend Parliament to promote the Infection Management Coalition’s White Paper

BIVDA, as part of the Infection Management Coalition (IMC), attended Parliament on Wednesday to promote recommendations made in the IMC’s White Paper to MPs. The White Paper establishes a clear, bold vision for infection control across four pillars: outbreak and pandemic preparedness; infection prevention; rapid treatment of time-critical infection; and antimicrobial stewardship. Doris-Ann led one of the four stands set…
Natalie Creaney
July 22, 2022
HighlightsHighlights Archive

NHS failing to meet vital AMR targets

The NHS is set to miss two critical targets in tackling AMR – as outlined in a five-year AMR action plan unveiled by the government in 2019. The targets expected to be missed are: reducing the number of three gram-negative bacteria from bloodstream infections in healthcare settings by 25% by March this year, and 50% by 2024. Current figures show…
Ben Kemp
April 22, 2022
HighlightsHighlights Archive

NICE undertakes world-first evaluation of antimicrobial drugs to tackle AMR

In a historic move, cefiderocol and ceftazidime–avibactam will become the first antimicrobial drugs authorised by NICE for use in the UK’s new subscription-style payment model. This forms part of a larger scheme with NHSE/I and DHSC to provide a greater incentive to research and develop much-needed antimicrobial drugs for the future. The dearth of new antimicrobials being developed and the…
Ben Kemp
April 14, 2022